Cargando…

Synaptopathy in CHMP2B frontotemporal dementia highlights the synaptic vesicle cycle as a therapeutic target

Detalles Bibliográficos
Autores principales:	Robbins, Miranda, Clayton, Emma L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396515/ https://www.ncbi.nlm.nih.gov/pubmed/35900412 http://dx.doi.org/10.4103/1673-5374.343905

Ejemplares similares

Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology
por: Clayton, Emma L., et al.
Publicado: (2015)

Frontotemporal Dementia Caused by CHMP2B Mutations
por: Isaacs, A.M, et al.
Publicado: (2011)

Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations
por: Urwin, Hazel, et al.
Publicado: (2010)

Cortical Frontoparietal Network Dysfunction in CHMP2B-Frontotemporal Dementia
por: Musaeus, Christian Sandøe, et al.
Publicado: (2021)

Retrovirus reactivation in CHMP2B(Intron5) models of frontotemporal dementia
por: Fort-Aznar, Laura, et al.
Publicado: (2020)

Frontotemporal dementia causative CHMP2B impairs neuronal endolysosomal traffic-rescue by TMEM106B knockdown
por: Clayton, Emma L, et al.
Publicado: (2018)

Neuroprotective activity of ursodeoxycholic acid in CHMP2B(Intron5) models of frontotemporal dementia
por: West, Ryan J.H., et al.
Publicado: (2020)

Early microgliosis precedes neuronal loss and behavioural impairment in mice with a frontotemporal dementia-causing CHMP2B mutation
por: Clayton, Emma L., et al.
Publicado: (2017)

Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B
por: Zhang, Yu, et al.
Publicado: (2017)

Endo‐lysosomal protein concentrations in CSF from patients with frontotemporal dementia caused by CHMP2B mutation
por: Toft, Anders, et al.
Publicado: (2023)

Tissue-type plasminogen activator is a modulator of the synaptic vesicle cycle
por: Yepes, Manuel
Publicado: (2016)

In vivo exploration of synaptic projections in frontotemporal dementia
por: Salmon, Eric, et al.
Publicado: (2021)

EMA's CHMP meeting highlights from September 2020
Publicado: (2020)

EMA releases highlights from the CHMP's July meeting
Publicado: (2020)

CHMP meeting highlights September 2021: Vaxzevria-related TTS
Publicado: (2021)

Presymptomatic cerebral blood flow changes in CHMP2B mutation carriers of familial frontotemporal dementia (FTD-3), measured with MRI
por: Lunau, Line, et al.
Publicado: (2012)

A novel splice‐site mutation in CHMP2B associated with frontotemporal dementia: The first report from China and literature review
por: Li, Chang, et al.
Publicado: (2023)

The important functional role of TDP-43 plays in amyotrophic lateral sclerosis-frontotemporal dementia
por: Chen, Liam
Publicado: (2020)

LIM kinases in synaptic plasticity and their potential as therapeutic targets
por: Halász, Éva, et al.
Publicado: (2020)

The enhanced association between mutant CHMP2B and spastin is a novel pathological link between frontotemporal dementia and hereditary spastic paraplegias
por: Chen, Yongping, et al.
Publicado: (2022)

Synaptopathies in Developmental and Epileptic Encephalopathies: A Focus on Pre-synaptic Dysfunction
por: Spoto, Giulia, et al.
Publicado: (2022)

TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III
por: Jun, Mi-Hee, et al.
Publicado: (2015)

Therapeutic and diagnostic challenges for frontotemporal dementia
por: D’Alton, Simon, et al.
Publicado: (2014)

Synaptopathies: synaptic dysfunction in neurological disorders – A review from students to students
por: Lepeta, Katarzyna, et al.
Publicado: (2016)

Could Perinatal Asphyxia Induce a Synaptopathy? New Highlights from an Experimental Model
por: Herrera, María Inés, et al.
Publicado: (2017)

Metabotropic glutamate receptor: A new possible therapeutic target for cochlear synaptopathy
por: Mahdi, Parvane, et al.
Publicado: (2022)

Distinct and dementia‐related synaptopathy in the hippocampus after military blast exposures
por: Almeida, Michael F., et al.
Publicado: (2021)

The pro-apoptotic JNK scaffold POSH/SH3RF1 mediates CHMP2B(Intron5)-associated toxicity in animal models of frontotemporal dementia
por: West, Ryan J H, et al.
Publicado: (2018)

Bringing synapses into focus: Recent advances in synaptic imaging and mass-spectrometry for studying synaptopathy
por: Hindley, Nicole, et al.
Publicado: (2023)

Immune synaptopathies: how maternal immune activation impacts synaptic function during development
por: Matteoli, Michela, et al.
Publicado: (2023)

Neurotransmission and the synaptic vesicle cycle.
por: Farsad, Khashayar, et al.
Publicado: (2002)

Hemifusion in Synaptic Vesicle Cycle
por: Kweon, Dae-Hyuk, et al.
Publicado: (2017)

Synaptic tau: A pathological or physiological phenomenon?
por: Robbins, Miranda, et al.
Publicado: (2021)

Frontotemporal dementia
por: Warren, Jason D, et al.
Publicado: (2013)

Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia
por: Sogorb-Esteve, Aitana, et al.
Publicado: (2022)

The emerging world of subcellular biological medicine: extracellular vesicles as novel biomarkers, targets, and therapeutics
por: Coleman, Leon G.
Publicado: (2021)

Molecular and Cellular Mechanisms of Synaptopathies
por: Ardiles, Alvaro O., et al.
Publicado: (2017)

Improving response inhibition systems in frontotemporal dementia with citalopram
por: Hughes, Laura E., et al.
Publicado: (2015)

CSF synaptic protein concentrations are raised in those with atypical Alzheimer’s disease but not frontotemporal dementia
por: Clarke, Mica T. M., et al.
Publicado: (2019)

Astroglial toxicity promotes synaptic degeneration in the thalamocortical circuit in frontotemporal dementia with GRN mutations
por: Marsan, Elise, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0bop3am8iavrkvb1gt8c9k9op7